Involvement of endosomal and synaptic A in models of Alzheimer's disease. Willén, Katarina 2017 Document Version: Publisher's PDF, also known as Version of record Link to publication Citation for published version (APA): Willén, K. (2017). Involvement of endosomal and synaptic Aβ in models of Alzheimer's disease. [Doctoral Thesis (compilation), Experimental Dementia Research]. Lund University: Faculty of Medicine. Total number of authors: 1 General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. LUND UNIVERSITY PO Box 117 221 00 Lund +46 46-222 00 00 k a t a r in a w il l é n I n v Involvement of endosomal o lv e m and synaptic Aβ in models of e n t o f e Alzheimer's disease n d o s o m katarina willén al a Faculty oF Medicine | lund university n d s y n a p t ic A β i n m o d e ls o f A l z h e i m e r 's d i s e a s e Department of Experimental Medical Science 8 9 5 5 Lund University, Faculty of Medicine 9 1 2 Doctoral Dissertation Series 2017:177 6 0 7 1 ISBN 978I-S9S1N-7 1661592--585292-08 7891 7:177 9 Involvement of endosomal and synaptic Aβ in models of Alzheimer's disease 1 2 Involvement of endosomal and synaptic Aβ in models of Alzheimer's disease Katarina Willén DOCTORAL DISSERTATION by due permission of the Faculty of Medicine, Lund University, Sweden. To be defended at Segerfalksalen, Wallenberg Neuroscience Center, Lund University. December 7th 2017 at 13:00. Faculty opponent Professor Tobias Hartmann Saarland University, Homburg, Germany 3 Organization Document name LUND UNIVERSITY Doctoral thesis Faculty of Medicine, Dept. of Experimental Medical Science, Experimental Dementia Research Unit Date of issue 2017-11-16 Author: Katarina Willén Sponsoring organization Title and subtitle: Involvement of endosomal and synaptic Aβ in models of Alzheimer's disease Abstract Alzheimer’s disease (AD) is a devastating chronic neurodegenerative disease that accounts for 60-80% of all dementia cases. AD is characterized by progressive decline in cognitive function, aggregated β-amyloid (Aβ) in amyloid plaques, neurofibrillary tangles (NFTs), dystrophic neurites and loss of synapses and neurons. However, the earliest changes in the pathology of AD occur in the endocytic pathway with enlarged endosomes and accumulation of multivesicular bodies (MVBs), lysosomes and autophagic vacuoles. Aβ accumulates and aggregates particularly in MVBs in synaptic terminals, with signs of synaptic pathology. It is also well known that synaptic loss is a better correlate of cognitive decline than plaques or NFTs. Hence, the aim of this thesis was to investigate the role of Aβ in the endocytic pathway and at synapses in AD. We found that extracellularly applied Aβ1-42 is taken up by primary neurons at synapses, and more by excitatory CAMKIIα-positive than inhibitory GAD67-positive ones. However, with no clear preference to the pre- or the post-synaptic site. Aβ1-42 uptake led to enlarged diameter of MVBs and aggregation of Aβ1-42 in endocytic vesicles. With time, loss of impermeability appeared in the endocytic pathway with oligomeric or fibrillar structures extending out extracellularly from late endocytic vesicles. Indicative of a role in plaque formation, markers of the endosomal sorting complexes required for transport (ESCRT)-components were found in plaques of AD-transgenic mouse models. We also show that APP traffics in the same subpopulation of MVBs as EGFR and is degraded in the lysosome. Depleting cells of ESCRT-components led to reduced secretion of Aβ and a marked intracellular accumulation of Aβ and APP. Hence, we suggest a scenario where disturbances in the MVB pathway, caused by Aβ, or vice versa, lead to a vicious circle of more Aβ accumulation and aggregation. We further investigated the native state of this early Aβ aggregation in a mouse model of AD showing that focal β-sheet formation begins already before the onset of plaques. Here, we also confirmed the findings of Aβ accumulation leading to disrupted synaptic terminals in AD-transgenic mice brain. Additionally, we present data supporting the requirement of APP for normal synaptic composition of mature neurons. Taken together, this work further strengthens the significance of Aβ accumulation and aggregation in the endocytic pathway at synapses, as an early event in AD pathogenesis. Key words: Alzheimer’s disease; Amyloid; Multivesicular body; APP Classification system and/or index terms (if any) Supplementary bibliographical information Language ISSN and key title 1652-8220 ISBN 978-91-7619-559-8 Recipient’s notes Number of pages 80 Price Security classification I, the undersigned, being the copyright owner of the abstract of the above-mentioned dissertation, hereby grant to all reference sources permission to publish and disseminate the abstract of the above-mentioned dissertation. Signature Date 2017-11-0 6 4 Involvement of endosomal and synaptic Aβ in models of Alzheimer's disease Katarina Willén 5 Coverphoto by Katarina Willén Copyright Katarina Willén and the respective publishers Faculty of Medicine Department of Experimental Medical Science Lund University, Faculty of Medicine Doctoral Dissertation Series 2017:177 ISBN 978-91-7619-559-8 ISSN 1652-8220 Printed in Sweden by Media-Tryck, Lund University Lund 2017 6 ’Truth in science can be defined as the working hypothesis best suited to open the way to the next one’ Konrad Lorenz ’Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.’ Marie Curie 7 8
Description: